.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Mycophenolic acid - Generic Drug Details

« Back to Dashboard
Mycophenolic acid is the generic ingredient in two branded drugs marketed by Teva Pharms Usa, Mylan Pharms Inc, Apotex Inc, and Novartis, and is included in four NDAs. There are three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

This ingredient has fifty-seven patent family members in thirty-eight countries.

There are sixteen drug master file entries for mycophenolic acid. Seven suppliers are listed for this compound.

Summary for Generic Name: mycophenolic acid

Tradenames:2
Patents:3
Applicants:4
NDAs:4
Drug Master File Entries: see list16
Suppliers / Packaging: see list7
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: mycophenolic acid

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
MYFORTIC
mycophenolic acid
TABLET, DELAYED RELEASE;ORAL050791-002Feb 27, 2004RXYes6,306,900► subscribeY ► subscribe
Novartis
MYFORTIC
mycophenolic acid
TABLET, DELAYED RELEASE;ORAL050791-001Feb 27, 2004RXNo6,306,900► subscribeY ► subscribe
Novartis
MYFORTIC
mycophenolic acid
TABLET, DELAYED RELEASE;ORAL050791-002Feb 27, 2004RXYes6,025,391► subscribeY ► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: mycophenolic acid

Country Document Number Estimated Expiration
Luxembourg91094► subscribe
Malaysia119049► subscribe
South Korea20000005360► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: MYCOPHENOLIC ACID

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
094Luxembourg► subscribe91094, EXPIRES: 20181010
C017/2004Ireland► subscribeSPC017/2004, 20060201, EXPIRES: 20171023
2004 00024Denmark► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc